IL137121A0 - Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha - Google Patents
Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alphaInfo
- Publication number
- IL137121A0 IL137121A0 IL13712199A IL13712199A IL137121A0 IL 137121 A0 IL137121 A0 IL 137121A0 IL 13712199 A IL13712199 A IL 13712199A IL 13712199 A IL13712199 A IL 13712199A IL 137121 A0 IL137121 A0 IL 137121A0
- Authority
- IL
- Israel
- Prior art keywords
- heavy chain
- light chain
- alpha
- antibody
- variable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10627598P | 1998-10-30 | 1998-10-30 | |
PCT/US1999/025495 WO2000026667A1 (en) | 1998-10-30 | 1999-10-29 | Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
Publications (1)
Publication Number | Publication Date |
---|---|
IL137121A0 true IL137121A0 (en) | 2001-06-14 |
Family
ID=22310524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13712199A IL137121A0 (en) | 1998-10-30 | 1999-10-29 | Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1051620B1 (ja) |
JP (1) | JP2002529054A (ja) |
AT (1) | ATE329263T1 (ja) |
AU (1) | AU1458500A (ja) |
CA (1) | CA2317808A1 (ja) |
DE (1) | DE69931756T2 (ja) |
IL (1) | IL137121A0 (ja) |
WO (1) | WO2000026667A1 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9918788D0 (en) | 1999-08-10 | 1999-10-13 | Leuven K U Res & Dev | Antithrombotic effect of platelet glycoprotein 1b blocking monoclonal Fab fragments |
DE10019967A1 (de) * | 2000-04-20 | 2001-10-25 | Fenning Biomed Gmbh Dr | Antikörper gegen natives gp96, deren Herstellung und Verwendung |
US7521053B2 (en) | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
US7658924B2 (en) | 2001-10-11 | 2010-02-09 | Amgen Inc. | Angiopoietin-2 specific binding agents |
EP1539235A2 (en) | 2002-07-01 | 2005-06-15 | Human Genome Sciences, Inc. | Antibodies that specifically bind to reg iv |
WO2004005890A2 (en) * | 2002-07-03 | 2004-01-15 | The Trustees Of The University Of Pennsylvania | Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
AU2003298112A1 (en) * | 2002-11-13 | 2004-06-03 | Micromet Ag | Method for identifying antigen specific b cells |
AU2004259406A1 (en) * | 2003-06-30 | 2005-02-03 | Bio-Technology General (Israel) Ltd. | Antibodies and uses thereof |
EP1749536A1 (en) * | 2005-08-03 | 2007-02-07 | Thrombotargets Europe, S.L. | Activated factor X stimulants as new antihemorrhagic agents for topical use |
JO2913B1 (en) | 2008-02-20 | 2015-09-15 | امجين إنك, | Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses |
DK2186829T3 (en) * | 2008-11-14 | 2015-04-07 | Canadian Blood Services | Antibodies to GPIbalfa |
CN102905727B (zh) * | 2009-10-30 | 2016-12-07 | 詹森生物科技公司 | Il-17a拮抗剂 |
PE20221325A1 (es) * | 2019-12-10 | 2022-09-09 | Ccoa Therapeutics Inc | Anticuerpos anti-glicoproteina ib alfa humanizada (gpibalpha) |
BR112022011957A2 (pt) * | 2019-12-20 | 2022-09-06 | Medimmune Llc | Composições e métodos de tratamento de câncer com receptores de antígenos quiméricos visando glipicana 3 |
BR112022025632A2 (pt) * | 2020-06-23 | 2023-01-17 | Kadmon Corp Llc | Anticorpos anti-pd-1 e proteínas de fusão |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5877155A (en) * | 1995-03-17 | 1999-03-02 | The Research Foundation Of State University Of New York | Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX |
US5817748A (en) * | 1995-03-17 | 1998-10-06 | The Research Foundation Of State University Of New York | Mimotopes of human Platelet glycoprotein Ib/IX |
-
1999
- 1999-10-29 DE DE69931756T patent/DE69931756T2/de not_active Expired - Lifetime
- 1999-10-29 AU AU14585/00A patent/AU1458500A/en not_active Abandoned
- 1999-10-29 IL IL13712199A patent/IL137121A0/xx unknown
- 1999-10-29 WO PCT/US1999/025495 patent/WO2000026667A1/en active IP Right Grant
- 1999-10-29 AT AT99971513T patent/ATE329263T1/de not_active IP Right Cessation
- 1999-10-29 EP EP99971513A patent/EP1051620B1/en not_active Expired - Lifetime
- 1999-10-29 CA CA002317808A patent/CA2317808A1/en not_active Abandoned
- 1999-10-29 JP JP2000579997A patent/JP2002529054A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ATE329263T1 (de) | 2006-06-15 |
DE69931756D1 (de) | 2006-07-20 |
CA2317808A1 (en) | 2000-05-11 |
AU1458500A (en) | 2000-05-22 |
JP2002529054A (ja) | 2002-09-10 |
WO2000026667A1 (en) | 2000-05-11 |
EP1051620A4 (en) | 2005-01-12 |
DE69931756T2 (de) | 2007-05-24 |
EP1051620A1 (en) | 2000-11-15 |
WO2000026667A9 (en) | 2001-04-12 |
EP1051620B1 (en) | 2006-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL137121A0 (en) | Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha | |
SE9201331D0 (sv) | Protein l och hybridproteiner daerav | |
EP0724456A4 (en) | ANTIBODIES AGAINST CD40 | |
EP0728215A4 (en) | METHOD FOR BINDING MATERIAL TO THE -g (b) AMYLOID PEPTIDE | |
AU7793991A (en) | Recombinant library screening methods | |
WO1998050433A3 (en) | Human monoclonal antibodies to epidermal growth factor receptor | |
AU3117201A (en) | Methods and compositions for generating human monoclonal antibodies | |
UY35948A (es) | Anticuerpos contra el receptor del factor de crecimiento similar a insulina | |
CR7343A (es) | Anticuerpos para cd40 | |
MX9504802A (es) | Anticuerpos anti-egfr y fvs de cadena simple anti-egfr. | |
MXPA04001344A (es) | Anticuerpos humanos antagonistas contra htnfsf13b. | |
WO2003060080A3 (en) | Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them | |
RS80704A (en) | ANTI- av?6.ANTIBODIES | |
AU3066489A (en) | Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore | |
MX9602971A (es) | Anticuerpos humanizados contra la molecula vla-4 de adhesion de leucocitos. | |
EA201300481A1 (ru) | АНТИТЕЛА, ОБЛАДАЮЩИЕ ПОВЫШЕННОЙ АФФИННОСТЬЮ К СВЯЗЫВАНИЮ С Fc-РЕЦЕПТОРОМ И ЭФФЕКТОРНОЙ ФУНКЦИЕЙ | |
AU2821195A (en) | Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin | |
NZ512553A (en) | Human monoclonal antibodies to cytotoxic T lymphocyte antigen 4 (CTLA-4) | |
DK0720624T3 (da) | Omdirigering af antistoffer | |
AU2002951409A0 (en) | Methods for regulating cancer | |
CA2457362A1 (en) | Human monoclonal rabies virus neutralizing antibodies, and methods for making and using the same | |
FR2560212B1 (fr) | Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps | |
MX9702422A (es) | Anticuerpos recombinantes contra fas y adn para los mismos. | |
SE9500148D0 (sv) | Antibodies for use in cancer therapy and diagnosis | |
KR970005097A (ko) | 암태아성 항원(cea)에 대한 단클론성 항체 |